ABSTRACT
Introduction
Alpha 2 adrenoreceptor agonists (α 2 -agonists) have several characteristics that make them attractive as premedication for general anesthesia. These include sedation, anxiolysis, analgesia, prevention of autonomic reflex response, reduced anesthetic requirements, improved intraoperative stability and facilitation of induction of anesthesia [1] [2] [3] .
Xylazine 4, 5 , romifidine 6, 7 , medetomidine 8, 9 and dexmedetomidine 10, 11 have all been used in dogs for sedation and anesthetic premedication. However, α 2 -agonists, through stimulation of central and peripheral adrenoreceptors, significantly affect cardiovascular function, which becomes most significant in sick, unstable, or cardiovascular compromised patients [1] [2] [3] . The main negative cardiovascular effects of all α 2 -agonists include bradycardia and associated arrhythmias (1st and 2nd degree atrioventricular heart block), a dramatic reduction in cardiac output by up to 50%, and an increase in systemic vascular resistance (SVR) 3, 4 .
The hemodynamic effects are typically dose related with the administration of α 2 -agonists. Lower doses of these drugs may be associated with more predominant central nervous system (CNS) effects, whereas higher doses probably cause a more pronounced stimulation of peripheral adrenoreceptors and vasoconstriction 1, 4 .
Pharmacopuncture, the injection of subclinical doses of drugs into acupoints, has been proved to be a very successful practice in domestic animals [12] [13] [14] . A micro-dose of acepromazine According to Traditional Chinese Medicine, the acupoint Yin Tang has a sedative effect in humans and animals [15] [16] [17] [18] . In people, acupressure and manual acupuncture on the Yin Tang point was associated with pronounced changes in the bispectral index (BIS) values, with significant sedative effect 17, 18 .
The aim of this study was to investigate the sedative and clinical effects of the pharmacopuncture with xylazine (1/10 of the dose), compared to the conventional dose of an intramuscular injection in dogs.
Methods

This study was approved by the Institutional Animal
Research Ethical Committee (protocol number 563/10).
Twelve mixed breed dogs, weighting 10±2kg were evaluated in this study. Health status was established on the basis of a physical examination and normal complete blood count, biochemistry perfil and electrocardiogram using standard methods.
After withdrawal of food and water for 12 and 3 hours, respectively, the dogs were randomly assigned to receive one of the following two treatments, in a double-blind design: the control group The following measurements were performed: Heart rate (HR) and rhythm (ECG) were monitored using a cardiac monitor The data were analyzed using Graphpad software. Main effects of treatment or time within each treatment group were evaluated using analysis of variance for repeated measures. In analyses that demonstrated a significant main effect, pairwise comparisons of the appropriate means were made using Tukey's method for multiple pairwise comparisons. For sedation score, the Mann-Whitney test was applied. In all tests, statistical significance was assigned to p<0.05.
Results
At baseline, there were no significant differences between the two groups in HH, ECG, SABP, RR, RT, blood glucose and sedation score.
Xylazine IM significantly decreased the heart rate. The lowest heart rate was 40 beats per minute and it occurred from 30 to 45 min post-xylazine injection (X-IM). Five of six X-IM dogs showed bradyarrhythmia, whereas in X-Yintang treatment group, bradyarrhythmia was not observed (Table 1) . 
Glucose (mg mL -1 ) In addition, a higher incidence of ECG abnormalities (sinus arrest, first degree AV block, second degree AV block) were observed in X-IM group ( Table 2) .
The systolic arterial blood pressure did not change between treatment groups, except from 30 to 45 min, when this parameter was lower in X-IM group in comparison with X-Yintang group (Table 1) .
In X-IM group, SABP was significantly lower at 30 min after xylazine administration when compared with the baseline values ( Table 1) .
Cardiac arrythmias# Groups SA 1st degree AV heart block 2nd degree AV heart block X-IM 5/6 3/6 1/6 X-Yintang ------------ Respiratory rates were not significantly different between the treatment groups at any time point. However, lower RR was observed from 30 to 60 min after the drug injection, when compared with the baseline values in both groups (Table 1) .
Rectal temperature was lower from 45 to 60 min in X-IM treatment group when compared with X-Yintang treatment group.
Minimal changes were observed in blood glucose concentration. Dogs from the X-IM group had blood glucose significantly higher than dogs from the X-Yintang group only at 60 min after xylazine injection (Table 1) .
Vomiting was observed in four of the six dogs in X-IM Several studies have shown that arterial blood pressure has a biphasic response when α 2 -agonists drugs are administered 7, 8 .
In this study, we did not observe an initial increase in SABP in either of the groups. This result supports the findings of Monteiro et al. 5 following xylazine IM injection at a dose of 0.5 and 1mg kg -1 in dogs. The characteristics of the blood pressure changes appear to be in part determined by dose. Higher doses cause longer duration hypertension associated with a persistent increase in SVR 2, 3 . At lower doses, central effects predominate and blood pressure decreases to pre-treatment or below pre-treatment values 6, 19 . Furthermore, another studies have shown that arterial blood pressure has a biphasic response observed after intravenous administration, but not after intramuscular administration 4, 19 . In our study, arterial pressure decreased after xylazine treatment in both groups, which may be attributed to the sedative effect induced by α 2 -agonists drugs. Additionally, in X-IM group this effect may have been increased by the bradycardia 8 .
Xylazine has little effect on pulmonary function when administered at clinical doses. However, transient dose-dependent decreases in respiratory rate have also been reported 1, 2, 19 . In our study, although median RR decreased significantly in both treatment groups, the decrease was unlikely to be clinically relevant, which is in agreement with other studies in dogs 5, 20 .
Previous studies have reported a decrease in body temperature in dogs given α 2 -agonists 5, 7 . This effect is thought to result from decreased heat production secondary to muscle relaxation or from a direct effect of the drug within the thermoregulatory system 19 . In the present study, despite mild reduction in the rectal temperatures, body temperatures remained within clinically acceptable limits in both groups.
Transient hyperglycemia have been reported in several species sedated with xylazine or that are anesthetized using a regime that incorporates xylazine 21, 22 . Blood glucose values tended to be higher in X-IM than X-Yintang, although significant difference was observed only at 60 min after xylazine injection.
This result is in agreement with early studies that showed increased glucose values dose-dependently following xylazine treatment 23, 24 .
Vomiting has previously been reported following the administration of xylazine to dogs 2, 5 . Alpha 2 -agonists typically 
Discussion
Despite the desirable clinical properties of the α 2 -agonists, the main limiting factor of their use is the adverse cardiovascular effect [1] [2] [3] . Marked decreases in heart rate and cardiac output, increases in total vascular resistance, and transient changes in blood pressure, are expected dose-dependent effects of xylazine 1, 2 .
It is well-established that administering xylazine consistently produces bradycardia 1, 4, 5 , and the results of the current study support this finding. As expected, the majority of the dogs in the X-IM group showed bradycardia (HR<60bpm), while induce vomiting by stimulating the chemoreceptor trigger zone, which is in close proximity to the locus coeruleus in the brain 1, 2 .
Xylazine induces vomiting during early sedation in as many as 50% of dogs and 90% of cats 3 . In the present study, the prevalence of vomiting in dogs which received xylazine IM was nearly 66%, whereas in Yin Tang xylazine treated dogs, the prevalence of vomiting was reduced to 0% and this might be attributable to the low dose used in this treatment group. These finds support the effect of pharmacopuncture to enhance the effect of subclinical doses of drugs, with the advantage of reduction of undesirable side effects, as described by Luna et al. 13 .
Based on the sedation score, mild to moderate sedation was produced in the X-IM group, with the maximal sedative effect The sedative effect established in X-Yintang treatment group is consistent with previous reports, showing the potentiation effect of subclinical doses of drugs injected in an acupoint, i.e. pharmacopuncture [12] [13] [14] . In horses, 1/10 of the dose of acepromazine at GV1 acupoint was able to maintain a certain degree of sedation at 60 min, indicating a long-lasting effect of pharmacopuncture 13 .
Several acupoints may be used for analgesia in surgical procedures and also for sedation [26] [27] [28] [29] . Kim and Nam 28 showed sedative effect following an acupuncture application in the Yintang and GV20 acupoints in conscious dogs.
The mechanism by which acupuncture produces analgesia and sedation remains unclear. However, the opioid system and the adrenergic system have been considered to play important roles in mediating the effects of acupuncture [30] [31] [32] .
Recent studies have investigated the role of central norepinephrine (NE) in acupuncture 33, 34 . It was reported that acupuncture reduced NE levels in certain brain areas as well as in the blood circulation 35 . Similarly, the sedative effect mediated by α 2 -agonists is linked with receptors located primarily in locus coeruleus neurons on the pons and lower brainstem 36 . Alpha2-agonists bind with and intrinsically change the membranes of the α 2 -adrenoreceptors, preventing further release of the neurotransmitter NE. Centrally, NE is necessary for arousal. If the release of norepinephrine is blocked, the net result is sedation 2,3 .
In addition, previous studies have reported that the sedative effect of acupuncture may be reversed by the administration of a α 2 -adrenergic receptor antagonist, such as yohimbine 36, 37 or atipamezole 32 . Based on these finds, the sedative effect observed in the X-Yintang group, may, at least in part, be attributed to the activation of the α 2 -adrenergic system induced by the acupoint stimulation mediated by the subclinical dose of xylazine administration.
Conclusion
Pharmacopuncture with xylazine induced clinically relevant sedative effects in dogs, with the advantage of reduction of undesirable side effects associated with α 2 -agonists, including bradycardia, arrhythmias, and emesis.
